BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34075764)

  • 21. A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors.
    von Eyben FE
    Clin Biochem; 2001 Sep; 34(6):441-54. PubMed ID: 11676973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and characterization of 2 testicular germ cell markers, Glut3 and CyclinA2.
    Howitt BE; Brooks JD; Jones S; Higgins JP
    Appl Immunohistochem Mol Morphol; 2013 Oct; 21(5):401-7. PubMed ID: 23343953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of CDX2, GATA3, and DOG1 in the diagnosis of testicular neoplasms: an immunohistochemical study of 109 cases.
    Osman H; Cheng L; Ulbright TM; Idrees MT
    Hum Pathol; 2016 Feb; 48():18-24. PubMed ID: 26772394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10-year experience.
    Bosl GJ; Geller NL; Cirrincione C; Nisselbaum J; Vugrin D; Whitmore WF; Golbey RB
    Am J Med; 1983 Jul; 75(1):29-35. PubMed ID: 6190398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term follow up experience of comprehensive treatment of testicular mixed germ cell tumors].
    Ye JF; Wang B; Ma LL; Zhao L; Wang GL; Hong K
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):648-651. PubMed ID: 28816282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
    Neumann A; Keller T; Jocham D; Doehn C
    Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SALL4 is a novel diagnostic marker for testicular germ cell tumors.
    Cao D; Li J; Guo CC; Allan RW; Humphrey PA
    Am J Surg Pathol; 2009 Jul; 33(7):1065-77. PubMed ID: 19390421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical presentation of testicular germinal cancer].
    Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
    Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biomarkers in testicular cancer.].
    Mayor-de-Castro J; Aragón-Chamizo J; Caño-Velasco J; Hernández-Fernández C
    Arch Esp Urol; 2022 Mar; 75(2):113-117. PubMed ID: 35332880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum lactate dehydrogenase isoenzyme 1. An early indicator of relapse in patients with testicular germ cell tumors.
    Edler von Eyben F; Lindegaard Madsen E; Blaabjerg O; Hyltoft Petersen P
    Acta Oncol; 1995; 34(7):925-9. PubMed ID: 7492382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers in Testicular Cancer: Classic Tumor Markers and Beyond.
    Egan J; Salari K
    Urol Clin North Am; 2023 Feb; 50(1):133-143. PubMed ID: 36424077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
    von Eyben FE; Blaabjerg O; Hyltoft-Petersen P; Madsen EL; Amato R; Liu F; Fritsche H
    Clin Chem Lab Med; 2001 Jan; 39(1):38-44. PubMed ID: 11256799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between clinical and pathological staging in low stage nonseminomatous germ cell testicular tumors.
    Pizzocaro G; Nicolai N; Salvioni R; Piva L; Faustini M; Zanoni F; Milani A
    J Urol; 1992 Jul; 148(1):76-9. PubMed ID: 1319508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Characterization of Testicular Germ Cell Tumors Using Tissue Microdissection.
    Cheng L; Mann SA; Lopez-Beltran A; Chovanec M; Santoni M; Wang M; Albany C; Adra N; Davidson DD; Cimadamore A; Montironi R; Zhang S
    Methods Mol Biol; 2021; 2195():31-47. PubMed ID: 32852755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review.
    Chakiryan NH; Dahmen A; Cucchiara V; Briganti A; Montorsi F; Salonia A; Spiess PE; Necchi A
    J Urol; 2021 Jun; 205(6):1569-1576. PubMed ID: 33617328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic markers for germ cell neoplasms: from placental-like alkaline phosphatase to micro-RNAs.
    Rajpert-De Meyts E; Nielsen JE; Skakkebaek NE; Almstrup K
    Folia Histochem Cytobiol; 2015; 53(3):177-88. PubMed ID: 26306513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
    Schwartz MK
    Tumour Biol; 1987; 8(2-3):106-8. PubMed ID: 2452467
    [No Abstract]   [Full Text] [Related]  

  • 39. [Relationship between testicular microcalcifications and clinical characteristics in patients with testicular cancer].
    Fernandez Alcaraz DA; García Bailón AM; Millán Alanís JM; Gutiérrez González A; Gómez Guerra LS; Guillen Lozoya AH
    Rev Int Androl; 2020; 18(3):96-100. PubMed ID: 31383611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testicular Cancer Biomarkers: A Role for Precision Medicine in Testicular Cancer.
    Leão R; Ahmad AE; Hamilton RJ
    Clin Genitourin Cancer; 2019 Feb; 17(1):e176-e183. PubMed ID: 30497810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.